**Molecular Mechanism and Rationale**
The proposed mechanism centers on alectinib's potential direct interaction with the ITGAM/CD11b subunit of complement receptor 3 (CR3), a critical heterodimeric integrin receptor composed of CD11b (ITGAM) and CD18 (ITGB2) subunits. CR3 functions as the primary microglial receptor for complement component C1q, facilitating the recognition and phagocytic elimination of C1q-opsonized synapses during complement-mediated synaptic pruning. The molecular architect
## Mechanistic Overview
miR-33 Antisense Oligonucleotide Hyper-Lipidation Strategy starts from the claim that modulating miR-33/ABCA1 within the disease context of molecular biology can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview miR-33 Antisense Oligonucleotide Hyper-Lipidation Strategy starts from the claim that modulating miR-33/ABCA1 within the disease context of molecular biology can redirect a disease-relevant process. The original descript
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Neuroinflammationmolecular biology
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
8/11
dimensions won
ITGAM/CD11b direct binding explains micr
3/11
dimensions won
miR-33 Antisense Oligonucleotide Hyper-L
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.66
0.70
Evidence
0.62
0.75
Novelty
0.68
0.70
Feasibility
0.74
0.51
Impact
0.68
0.65
Druggability
0.56
0.55
Safety
0.55
0.45
Competition
0.58
0.50
Data
0.72
0.70
Reproducible
0.66
0.65
KG Connect
0.50
0.12
Score Breakdown
Dimension
ITGAM/CD11b direct binding exp
miR-33 Antisense Oligonucleoti
Mechanistic
0.660
0.700
Evidence
0.620
0.750
Novelty
0.680
0.700
Feasibility
0.740
0.510
Impact
0.680
0.650
Druggability
0.560
0.550
Safety
0.550
0.450
Competition
0.580
0.500
Data
0.720
0.700
Reproducible
0.660
0.650
KG Connect
0.500
0.122
Evidence
ITGAM/CD11b direct binding explains microglial phagocytosis
ITGAM/CD11b direct binding explains microglial pha
4 rounds · quality: 0.50
Theorist
1. **Glyco-C1q Lectin Bridging**
**Mechanism:** C1q binds directly to disease-altered N-glycans or O-glycans on myelin debris, apoptotic neurites, or synaptic membranes, while a separate C1q domain e...
Skeptic
# Critical Evaluation of C1q-Related Hypotheses
## Hypothesis 1: Glyco-C1q Lectin Bridging
### 1. Strongest Specific Weakness: Unfounded Dual-Domain Assumption
The hypothesis requires C1q to poss...
Domain Expert
# Domain Expert Evaluation: C1q-Related Hypotheses in Alzheimer's Disease
## Executive Summary
The Skeptic's fundamental challenge is well-founded: pursuing mechanistic studies on unvalidated prem...